CS MEDICA A/S Stock

Equities

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
4.901 ^DKK	-2.49%		-8.58%	+4.66%

May. 23	Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024
May. 17	CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

Duration

Period

Style

Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024	May. 23
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 17	CI
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	Apr. 30	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	Apr. 22	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	Apr. 12
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	Apr. 04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	Feb. 21
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	Feb. 20	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	Feb. 02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	Jan. 26	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	Dec. 27	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Dec 05, 2023	Dec. 05
CS Medica A/S Announces Financial Year Change	Nov. 22	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Nov. 22	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	Nov. 22	CI

May. 23

CS MEDICA receives 2 MDKK to support its short-term financial obligations.	May. 28	AQ
CS MEDICA A/S announces financial results for the first half of the financial year 2023/24	May. 17	AQ
CS MEDICA Aligns Financial Priorities: Transition to Calendar Year 2024 Postponed	May. 07	AQ
CS MEDICA A/S Enters New Partnership with Award-Winning OTC Company Holding a Strong Position in the Chronic Pain Segment in Germany	Apr. 30	AQ
CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company	Apr. 25	AQ